Investor’s Watch List: Fitbit, Inc. (FIT), Sprint Corporation (S), EnteroMedics Inc. (ETRM)

Fitbit, Inc. (FIT) had a active trading with around 11.64M shares changing hands compared to its three month average trading volume of 11.62M. The stock traded between $7.12 and $7.37 before closing at the price of $7.24 with -1.76% change on the day. The San Francisco California 94105 based company is currently trading 0.56% above its 52 week low of $7.12 and -62.57% below its 52 week high of $19.34. Both the RSI indicator and target price of 35.92 and $10.63 respectively, lead us to believe that it should be put on hold over the coming weeks.

Fitbit, Inc. provides wearable health and fitness tracking devices. It offers various products, including Fitbit Zip, an entry-level wireless tracker that allows users to track daily activity statistics, such as steps, distance, calories burned, and active minutes; Fitbit One, a clippable wireless tracker, which tracks floors climbed and sleep, as well as daily steps, distance, calories burned, and active minutes; Fitbit Flex, a wristband-style tracker that tracks steps, distance, calories burned, active minutes, and sleep; and Fitbit Charge, an activity and sleep wristband, which tracks steps, distance, calories burned, active minutes, floors climbed, and sleep. The company also provides Fitbit Alta, a customizable wristband that offers call, text, and calendar notifications when paired with the user’s phone and SmartTrack automatic exercise recognition; and Fitbit Charge HR, a wireless heart rate and activity wristband. In addition, it offers Fitbit Blaze, a smart fitness watch that provides multi-sport functionality, tracks outdoor cycling activity, and provides run cues; Fitbit Surge, a fitness watch that features a GPS watch, heart rate tracker, activity tracker, and smartwatch; Aria, a Wi-Fi connected scale that tracks weight, body fat percentage, and body mass index; and Fitbit accessories that include bands and frames for Fitbit Blaze, bands for Fitbit Alta, colored bands for Fitbit Flex, colored clips for Fitbit One and Fitbit Zip, device charging cables, wireless sync dongles, band clasps, sleep bands, and Fitbit apparel. The company offers its products through consumer electronics and specialty retailers, e-Commerce retailers, sporting goods and outdoors retailers, and wireless carriers; and corporate wellness channels, as well as directly worldwide. The company was formerly known as Healthy Metrics Research, Inc. and changed its name to Fitbit, Inc. in October 2007. Fitbit, Inc. was founded in 2007 and is headquartered in San Francisco, California.

Sprint Corporation (S) continued its upward trend with the stock climbing 0.92% or $0.08 to close the day at $8.73 on light trading volume of 11.43M shares, compared to its three month average trading volume of 19.81M. The Overland Park Kansas 66251 based company has been outperforming the wireless communications group over the past 52 weeks, with the stock gaining 230.68%, compared to the industry which has advanced 18.27% over the same period. With RSI of 57.67, the stock should still continue to rise and get closer to its one year target estimate of $7.28, making it a hold for now.

Sprint Corporation, through its subsidiaries, provides various wireless and wireline communications products and services to consumers, businesses, government subscribers, and resellers in the United States, Puerto Rico, and the U.S. Virgin Islands. The company operates in two segments, Wireless and Wireline. The Wireless segment offers wireless data communication services, including mobile productivity applications, such as Internet access, messaging, and email services; wireless photo and video offerings; location-based capabilities comprising asset and fleet management, dispatch services, and navigation tools; and mobile entertainment applications. It also provides wireless voice communications services that include local and long-distance wireless voice services, as well as voicemail, call waiting, three-way calling, caller identification, directory assistance, and call forwarding services. In addition, this segment offers voice and data services internationally through roaming arrangements; and customized wireless services to large companies and government agencies, as well as sells wireless devices, broadband devices, connected devices, and accessories to agents and other third-party distributors. The Wireline segment provides wireline voice and data communications, including domestic and international data communications using various protocols, such as multiprotocol label switching technologies, Internet protocol (IP), managed network services, Voice over IP, session initiated protocol, and traditional voice services to other communications companies, and targeted business and consumer subscribers, as well as for cable multiple system operators. Sprint Corporation offers its services under the Sprint, Boost Mobile, Virgin Mobile, and Assurance Wireless brands. The company was founded in 1899 and is headquartered in Overland Park, Kansas. Sprint Corporation is a subsidiary of SoftBank Group Corp.

EnteroMedics Inc. (ETRM) shares were down in last trading by -36.85% to $5.62. It experienced lighter than average volume on day. The stock decreased in value by almost -79.71% over the past week and grew 9038.21% in the past month. It is currently trading 127.46% above its 50 day moving average and 526.74% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -81.52% decrease in value from its one year high of $30.41. The RSI indicator value of 48.64, lead us to believe that it is a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

 

Investor’s Alert: EnteroMedics Inc. (ETRM), Archer-Daniels-Midland Company (ADM), McDermott International, Inc. (MDR)

EnteroMedics Inc. (ETRM) continued its downward trend with the stock declining -2.14% or $-0.3 to close the day at $13.7 on higher than average trading volume of 2.17M shares, compared to its three month average trading volume of 11.8M. The St. Paul Minnesota 55113 based company has been underperforming the medical appliances & equipment companies by 12343.26% for last three months and its recent gains have pushed the stock slightly up 585% YTD, versus the medical appliances & equipment industry which is up 5.37% for the same period. The RSI of 61.9 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Archer-Daniels-Midland Company (ADM) had a light trading with around 2.16M shares changing hands compared to its three month average trading volume of 3.35M. The stock traded between $43.33 and $43.78 before closing at the price of $43.56 with 0.28% change on the day. The Chicago Illinois 60601 based company is currently trading 50.49% above its 52 week low of $29.86 and -8.36% below its 52 week high of $47.88. Both the RSI indicator and target price of 37.57 and $45.08 respectively, lead us to believe that it should be put on hold over the coming weeks.

Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities and products. Its Agricultural Services segment offers agricultural commodities, such as oilseeds, corn, wheat, milo, oats, rice, and barley; and resells those commodities as food and feed ingredients, and raw materials for the agricultural processing industry. The segment is also involved in structured trade finance and the processing of wheat into wheat flour. Its Corn Processing segment offers ingredients used in the food and beverage industry, including sweeteners, starch, syrup, glucose, and dextrose; bio products; alcohol, amino acids, and other food and animal feed ingredients; and ethyl alcohol for industrial use as ethanol or as beverage grade. This segment also offers corn gluten feed and meal, and distillers’ grains; vegetable oil and protein meal; formula feeds, and animal health and nutrition products; and citric acids and glycols for food and industrial products, as well as operates a sugarcane ethanol plant. The company’s Oilseeds Processing segment processes soybeans and soft seeds into vegetable oils and protein meals. It offers ingredients for the food, feed, energy, and industrial products industries; crude vegetable and salad oils; partially refined oils; oilseed protein meals; peanuts, tree nuts, and peanut-derived ingredients; cottonseed flour for the pharmaceutical industry; cotton cellulose pulp for the chemical, paper, and filter markets; and agricultural commodity raw materials. Its Wild Flavors and Specialty Ingredients segment offers natural flavor ingredients, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, natural health and nutrition products, edible beans, and other specialty food and feed ingredients. The company is also involved in futures commission and insurance activities. Archer-Daniels-Midland Company was founded in 1898 and is headquartered in Chicago, Illinois.

McDermott International, Inc. (MDR) traded within a range of $7.36 to $7.55 after opening the day at $7.39. The company has seen its stock increase in value by 0.95% so far this year. The stock was up close to 0.54% on light volume in last trading session and closed at $7.46 per share. After the recent gain, the stock is currently holding -9.14% below its 52 week high of $8.21 and 239.09% above its 12-month low of $2.2. The shares are up by over 41.29% in the last three months, and the RSI indicator value of 57.73 is neither bullish nor bearish, tempting investors to stay on the sidelines.

McDermott International, Inc. provides engineering, procurement, construction and installation, and module fabrication services for upstream field developments worldwide. It operates through three segments: the Americas, Europe and Africa; the Middle East; and Asia. The company delivers fixed and floating production facilities, pipeline installations, and subsea systems from concept to commissioning for offshore and subsea oil and gas projects. Its operations include fabrication and offshore installation of fixed and floating structures; and the installation of pipelines and subsea systems, as well as provision of shallow water and deep water construction services. The company’s customers include national, integrated, and other oil and gas companies. McDermott International, Inc. was founded in 1923 and is headquartered in Houston, Texas.

 

Equities Trend Analysis: EnteroMedics Inc. (ETRM), Macy’s, Inc. (M), MGM Resorts International (MGM)

EnteroMedics Inc. (ETRM) retreated with the stock falling -8.5% or $-1.3 to close at $14 on active trading volume of 6.43M compared its three months average trading volume of 11.78M. The St. Paul Minnesota 55113 based company operating under the Medical Appliances & Equipment industry has been trending up for the last 52 weeks, with the shares price now 1011.11% up for the period and up by 600% so far this year. With price target of $140 and a 34900% rebound from 52-week low, EnteroMedics Inc. has plenty of upside potential, making it a hold with a view buy.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Macy’s, Inc. (M) had a light trading with around 6.35M shares changing hands compared to its three month average trading volume of 6.63M. The stock traded between $29.7 and $30.19 before closing at the price of $29.98 with 0.1% change on the day. The Cincinnati Ohio 45202 based company is currently trading 3.34% above its 52 week low of $29.7 and -33.36% below its 52 week high of $45.5. Both the RSI indicator and target price of  and $37.6 respectively, lead us to believe that it could rise over the coming weeks.

Macy’s, Inc., together with its subsidiaries, operates stores, Websites, and mobile applications. Its stores and Websites sell a range of merchandise, including apparel and accessories for men, women, and children; cosmetics; home furnishings; and other consumer goods. The company also operates stores that offer a range of women’s, men’s, and children’s apparel; shoes; fashion accessories; housewares; home textiles; intimate apparel; and jewelry. As of January 4, 2017, it operated approximately 880 stores in the United States, the District of Columbia, Guam, and Puerto Rico under the Macy’s, Bloomingdale’s, Bloomingdale’s Outlet, Macy’s Backstage, and Bluemercury brands, as well as Websites, including macys.com, bloomingdales.com, and bluemercury.com. In addition, it operates as a beauty products and spa retailer. The company was formerly known as Federated Department Stores, Inc. and changed its name to Macy’s, Inc. in June 2007. Macy’s, Inc. was founded in 1830 and is based in Cincinnati, Ohio.

MGM Resorts International (MGM) saw its value decrease by -1.38% as the stock dropped $-0.4 to finish the day at a closing price of $28.63. The stock was lighter in trading and has fluctuated between $16.18-$30.62 per share for the past year. The shares, which traded within a range of $28.35 to $29.16 during the day, are up by 8.74% in the past three months and up by 22.93% over the past six months. It is currently trading -1.82% below its 20 day moving average and 0.35% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $33.92 a share over the next twelve months. The current relative strength index (RSI) reading is 46.36.The technical indicator lead us to believe there will be no major movement any time soon, hold.

MGM Resorts International, through its wholly owned subsidiaries, owns and/or operates casino resorts in the United States and China. The company operates through two segments, Wholly Owned Domestic Resorts and MGM China. Its casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. Its casino operations include various slots, table games, and race and sports book wagering. The company operates 12 wholly owned resorts in the United States; and MGM Macau resort and casino in China, as well as develops an integrated casino, hotel, and entertainment resort on the Cotai Strip, Macau. The company also owns and operates Shadow Creek golf course, Primm Valley Golf Club, and Fallen Oak golf course. The company serves premium gaming customers; leisure and wholesale travel customers; business travelers; and group customers, including conventions, trade associations, and small meetings. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was founded in 1986 and is based in Las Vegas, Nevada.

 

Stocks in Review: AT&T Inc. (T), EnteroMedics Inc. (ETRM), Cisco Systems, Inc. (CSCO)

AT&T Inc. (T) traded within a range of $40.24 to $41.06 after opening the day at $40.66. The company has seen its stock decrease in value by -2.93% so far this year. The stock was up close to 0.02% on light volume in last trading session and closed at $40.81 per share. After the recent gain, the stock is currently holding -4.06% below its 52 week high of $43.89 and 27.97% above its 12-month low of $33.43. The shares are up by over 5.83% in the last three months, and the RSI indicator value of 49.8 is neither bullish nor bearish, tempting investors to stay on the sidelines.

AT&T Inc. provides telecommunications and digital entertainment services. The company operates through four segments: Business Solutions, Entertainment Group, Consumer Mobility, and International. The Business Solutions segment offers wireless, fixed strategic, legacy voice and data, and wireless equipment services to business, governmental, and wholesale customers, as well as individual subscribers. The Entertainment Group segment provides video entertainment and audio programming channels to approximately 25.4 million subscribers; broadband and Internet services to 12.4 million residential subscribers; local and long-distance voice services to residential customers, as well as DSL Internet access services; and voice services over IP-based technology, and technical support and other customer service functions and equipment. The Consumer Mobility segment offers wireless services to consumers, and wireless wholesale and resale subscribers, such as long-distance and roaming services. This segment provides postpaid and prepaid wireless voice and data communications services; consulting, advertising, and application and co-location services; and sells a variety of handsets, wirelessly enabled computers, and personal computer wireless data cards through company-owned stores, agents, or third-party retail stores, as well as accessories, such as carrying cases and hands-free devices. The International segment offers video entertainment services to residential customers in Latin America, as well as wireless data and voice communication services in Mexico. This segment provides digital television services under the DIRECTV and SKY brands; postpaid and prepaid wireless services to approximately 8.7 million subscribers under the AT&T, Iusacell, Unefon, and Nextel Mexico brands; and sells a range of handsets. The company was formerly known as SBC Communications Inc. and changed its name to AT&T Inc. in November 2005. AT&T Inc. was founded in 1983 and is based in Dallas, Texas.

EnteroMedics Inc. (ETRM) continued its upward trend with the stock climbing 56.5% or $10 to close the day at $27.7 on active trading volume of 21.28M shares, compared to its three month average trading volume of 11.44M. The St. Paul Minnesota 55113 based company has been outperforming the medical appliances & equipment group over the past 52 weeks, with the stock gaining 1982.71%, compared to the industry which has advanced 14.92% over the same period. With RSI of 98.41, the stock should still continue to rise and get closer to its one year target estimate of $140, making it a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Cisco Systems, Inc. (CSCO) gained $0.2 to close the day at a new closing price of $30.38, a 0.66% increase in value from its previous closing price that moved the stock 40.07% above its 52 week low of $22.46. A total of 21.03M shares exchanged hands during the day compared with its three month average trading volume of 22.27M. The stock, which fluctuated between $30.1 and $30.55 during the day, currently situated -3.92% below its 52 week high. The stock is up by 2.31% in the past one month and down by -2.63% over the past three months. With a one year target estimate of $33.11 and RSI of 52.74, the stock still has upside potential, making it a hold for now.

Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol (IP) based networking and other products related to the communications and information technology industry worldwide. It provides switching products, including fixed-configuration and modular switches, and storage products that provide connectivity to end users, workstations, IP phones, wireless access points, and servers; and next-generation network routing products that interconnect public and private wireline and mobile networks for mobile, data, voice, and video applications. The company also offers service provider video infrastructure, including set-top boxes, cable/telecommunications access products, and cable modems; and video software and solutions. In addition, it provides collaboration products comprising unified communications products, conferencing products, collaboration endpoints, and business messaging products; data center products, such as blade and rack servers, modular servers, fabric interconnects, software, and server access virtualization solutions; security products, including network and data center security, advanced threat protection, Web and email security, access and policy, unified threat management, and advisory, integration, and managed services; and other products, such as emerging technologies and other networking products. Further, the company offers wireless products consisting of wireless access points; network managed services; and standalone, switch-converged, and cloud managed solutions. Additionally, it provides technical support services and advanced services. The company serves businesses of various sizes, public institutions, governments, and communications service providers. Cisco Systems, Inc. sells its products directly, as well as through channel partners, such as systems integrators, service providers, other resellers, and distributors. The company was founded in 1984 and is headquartered in San Jose, California.

 

3 Stocks to Watch For: Advanced Micro Devices, Inc. (AMD), EnteroMedics Inc. (ETRM), Merrimack Pharmaceuticals, Inc. (MACK)

Advanced Micro Devices, Inc. (AMD) saw its value increase by 1.5% as the stock gained $0.17 to finish the day at a closing price of $11.49. The stock was lighter in trading and has fluctuated between $1.75-$12.42 per share for the past year. The shares are up by 70.22% in the past three months and up by 129.34% over the past six months. It is currently trading 3.03% above its 20 day moving average and 25.45% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $8.88 a share over the next twelve months. The current relative strength index (RSI) reading is 66.65.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. The company’s products primarily include x86 microprocessors as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs), and semi-custom System-on-Chip (SoC) products. It provides x86 microprocessors for desktop PCs under the AMD A-Series, AMD E-Series, AMD FX CPU, AMD Athlon CPU and APU, AMD Sempron APU and CPU, and AMD Pro A-Series APU brands; and microprocessors for notebook and 2-in-1s under the AMD A-Series, AMD E-Series, AMD C-Series, AMD Z-Series, AMD FX APU, AMD Phenom, AMD Athlon CPU and APU, AMD Turion, and AMD Sempron APU and CPU brands. The company also offers chipsets with and without integrated graphics features for desktop, notebook PCs, and servers, as well as controller hub-based chipsets for its APUs under the AMD brand; and AMD PRO mobile and desktop processors. In addition, it provides discrete desktop graphics products and discrete GPUs for notebooks under the AMD Radeon brand; professional graphics products under the AMD FirePro brand; and customer-specific solutions based on AMD’s CPU, GPU, and multi-media technologies. Further, the company offers microprocessors for server platforms under the AMD Opteron; embedded processor solutions for interactive digital signage, casino gaming, and medical imaging under the AMD Opteron, AMD Athlon, AMD Sempron, AMD Geode, AMD R-Series, and G-Series brands; and semi-custom SoC products that power the Sony Playstation 4 and Microsoft Xbox One game consoles. Advanced Micro Devices, Inc. sells its products through its direct sales force, independent distributors, and sales representatives. The company serves original equipment manufacturers, original design manufacturers, system builders, and independent distributors. Advanced Micro Devices, Inc. was founded in 1969 and is headquartered in Sunnyvale, California.

EnteroMedics Inc. (ETRM) shares were up in last trading by 92.6% to $17.7. It experienced higher than average volume on day. The stock increased in value by almost 785% over the past week and grew 32677.78% in the past month. It is currently trading 3204.82% above its 50 day moving average and 3926.84% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a 81.54% increase in value from its one year high of $132.3. The RSI indicator value of 97.41, lead us to believe that it may reverse gains in the near term.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Merrimack Pharmaceuticals, Inc. (MACK) opening the day at $4.8. The company has seen its stock decrease in value by -10.05% so far this year. The stock was up close to 1.94% on active volume in last trading session and closed at $3.67 per share. After the recent gain, the stock is currently holding -59.31% below its 52 week high of $9.02 and 6.07% above its 12-month low of $3.46. The shares are down by over -33.03% in the last three months, and the RSI indicator value of 31.49 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer primarily in the United States. The company offers ONIVYDE that is used for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. Its therapeutic oncology candidates in clinical development include MM-398, which is in Phase II clinical trials for the treatment of patients with previously untreated, metastatic pancreatic adenocarcinoma; Phase I clinical trials for the treatment of patients with glioma, pediatric solid tumors, and gastrointestinal tumors; and Phase I clinical trials for treating metastatic breast cancer. The company’s therapeutic oncology candidates also include MM-302 that is in Phase II clinical trials for the treatment of patients with ErbB2 (HER2) positive, locally advanced or metastatic breast cancer; and MM-121, which is in Phase II clinical trial for the treatment of patients with heregulin positive, advanced non-small cell lung cancer. In addition, its therapeutic oncology candidates consist of MM-141 that is in Phase II clinical trials for the treatment of previously untreated metastatic pancreatic cancer patients who have high serum levels of free IGF-1; and MM-151 and MM-141, which are in Phase I clinical trials for the treatment of patients with solid tumors. The company has license and collaboration agreements with Baxter International Inc., Baxter Healthcare Corporation, and Baxter Healthcare SA; development, license, and supply agreement with Watson Laboratories, Inc.; sublicense and collaboration agreement with PharmaEngine, Inc.; collaboration agreements with Dyax Corp. and Adimab LLC,; and license agreement with University of California. Merrimack Pharmaceuticals, Inc. was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

 

3 Stocks to Watch For: Chesapeake Energy Corporation (CHK), EnteroMedics Inc. (ETRM), Advanced Micro Devices, Inc. (AMD)

Chesapeake Energy Corporation (CHK) saw its value decrease by -2.37% as the stock dropped $-0.17 to finish the day at a closing price of $7.01. The stock was lighter in trading and has fluctuated between $1.5-$8.2 per share for the past year. The shares, which traded within a range of $6.99 to $7.28 during the day, are up by 5.41% in the past three months and up by 65.33% over the past six months. It is currently trading -3.85% below its 20 day moving average and 6.64% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $7.54 a share over the next twelve months. The current relative strength index (RSI) reading is 50.69.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids (NGL) from underground reservoirs in the United States. It operates in two segments, Exploration and Production; and Marketing, Gathering, and Compression. The company holds interests in natural gas resource plays, including the Haynesville/Bossier Shales in northwestern Louisiana and East Texas; the Marcellus Shale in the northern Appalachian Basin in Pennsylvania; and the Barnett Shale in the Fort Worth Basin of north-central Texas. It also holds interests in liquids-rich resource plays, such as the Eagle Ford Shale in South Texas; the Utica Shale in Ohio and Pennsylvania; the Anadarko Basin in northwestern Oklahoma and the Texas Panhandle; and the Niobrara Shale in the Powder River Basin in Wyoming. The company owns interests in approximately 32,400 oil and natural gas wells. As of December 31, 2015, it had estimated proved reserves of 1.504 billion barrels of oil equivalent. The company also provides oil, natural gas, and NGL marketing services comprising commodity price structuring, securing and negotiating gathering, hauling, processing and transportation, contract administration, and nomination services for Chesapeake-operated wells; and marketing services for third-party producers, as well as designs, engineers, fabricates, installs, and sells natural gas compression units, accessories, and equipment used in the production, treatment, and processing of oil and natural gas. Chesapeake Energy Corporation was founded in 1989 and is headquartered in Oklahoma City, Oklahoma.

EnteroMedics Inc. (ETRM) shares were up in last trading by 131.49% to $9.19. It experienced higher than average volume on day. The stock increased in value by almost 276.64% over the past week and grew 18026.23% in the past month. It is currently trading 2497.64% above its 50 day moving average and 2204.99% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a 84.54% increase in value from its one year high of $9.75. The RSI indicator value of 94.81, lead us to believe that it may reverse gains in the near term.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Advanced Micro Devices, Inc. (AMD) traded within a range of $11.11 to $11.49 after opening the day at $11.29. The company has seen its stock decrease in value by -0.18% so far this year. The stock was up close to 0.71% on light volume in last trading session and closed at $11.32 per share. After the recent gain, the stock is currently holding -8.86% below its 52 week high of $12.42 and 546.86% above its 12-month low of $1.75. The shares are up by over 62.64% in the last three months, and the RSI indicator value of 64.58 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. The company’s products primarily include x86 microprocessors as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs), and semi-custom System-on-Chip (SoC) products. It provides x86 microprocessors for desktop PCs under the AMD A-Series, AMD E-Series, AMD FX CPU, AMD Athlon CPU and APU, AMD Sempron APU and CPU, and AMD Pro A-Series APU brands; and microprocessors for notebook and 2-in-1s under the AMD A-Series, AMD E-Series, AMD C-Series, AMD Z-Series, AMD FX APU, AMD Phenom, AMD Athlon CPU and APU, AMD Turion, and AMD Sempron APU and CPU brands. The company also offers chipsets with and without integrated graphics features for desktop, notebook PCs, and servers, as well as controller hub-based chipsets for its APUs under the AMD brand; and AMD PRO mobile and desktop processors. In addition, it provides discrete desktop graphics products and discrete GPUs for notebooks under the AMD Radeon brand; professional graphics products under the AMD FirePro brand; and customer-specific solutions based on AMD’s CPU, GPU, and multi-media technologies. Further, the company offers microprocessors for server platforms under the AMD Opteron; embedded processor solutions for interactive digital signage, casino gaming, and medical imaging under the AMD Opteron, AMD Athlon, AMD Sempron, AMD Geode, AMD R-Series, and G-Series brands; and semi-custom SoC products that power the Sony Playstation 4 and Microsoft Xbox One game consoles. Advanced Micro Devices, Inc. sells its products through its direct sales force, independent distributors, and sales representatives. The company serves original equipment manufacturers, original design manufacturers, system builders, and independent distributors. Advanced Micro Devices, Inc. was founded in 1969 and is headquartered in Sunnyvale, California.

 

Stocks in the Spotlight: Host Hotels & Resorts, Inc. (HST), Micron Technology, Inc. (MU), EnteroMedics Inc. (ETRM)

Host Hotels & Resorts, Inc. (HST) had a active trading with around 19.88M shares changing hands compared to its three month average trading volume of 10.14M. The stock traded between $18.34 and $19.36 before closing at the price of $18.5 with -4.34% change on the day. The Bethesda Maryland 20817 based company is currently trading 60.13% above its 52 week low of $12.17 and -5.03% below its 52 week high of $19.51. Both the RSI indicator and target price of 54.91 and $17.5 respectively, lead us to believe that it should be put on hold over the coming weeks.

Host Hotels & Resorts, Inc. is a publicly owned real estate investment trust (REIT). The firm primarily engages in the ownership and operation of hotel properties. It invests in the real estate markets of United States. It also invests in Canada, Mexico, Chile, the United Kingdom, Italy, Spain, and Poland. The firm primarily invests in luxury and upper upscale hotels. It was formerly known as Host Marriott Corporation. Host Hotels & Resorts, Inc. was founded in 1927 and is based in Bethesda, Maryland.

Micron Technology, Inc. (MU) continued its downward trend with the stock declining -1.12% or $-0.25 to close the day at $22.11 on light trading volume of 19.75M shares, compared to its three month average trading volume of 26.39M. The Boise Idaho 83716 based company has been outperforming the semiconductor- memory chips group over the past 52 weeks, with the stock gaining 55.49%, compared to the industry which has advanced 52.6% over the same period. With RSI of 62.13, the stock should still continue to rise and get closer to its one year target estimate of $26.58, making it a hold for now.

Micron Technology, Inc. provides semiconductor systems worldwide. The company operates through four segments: Compute and Networking Business Unit, Storage Business Unit, Mobile Business Unit, and Embedded Business Unit. It offers DDR3 and DDR4 DRAM products for computers, servers, networking devices, communications equipment, consumer electronics, automotive, and industrial applications; mobile low-power DRAM products for smartphones, tablets, automotive, laptop computers, and other mobile consumer device applications; DDR2 and DDR DRAM, GDDR5 and GDDR5X DRAM, SDRAM, and RLDRAM products for networking devices, servers, consumer electronics, communications equipment, computer peripherals, automotive and industrial applications, and computer memory upgrades; and hybrid memory cube semiconductor memory devices for use in networking and computing applications. The company also provides NAND Flash products, which are electrically re-writeable, non-volatile semiconductor memory devices; client solid-state drives (SSDs) for notebooks, desktops, workstations, and other consumer applications; enterprise SSDs for server and storage applications; managed multi-chip package products; digital media products, including flash memory cards and JumpDrive products under the Lexar brand name. In addition, it manufactures products that are sold under other brand names; and resells flash memory products that are purchased from other NAND Flash suppliers. Further, the company provides 3D XPoint memory products; and NOR Flash, which are electrically re-writeable and semiconductor memory devices for automotive, industrial, connected home, and consumer applications. It markets its products to original equipment manufacturers and retailers through its internal sales force, independent sales representatives, and distributors; and through a Web-based customer direct sales channel, and channel and distribution partners. The company was founded in 1978 and is headquartered in Boise, Idaho.

EnteroMedics Inc. (ETRM) shares were up in last trading by 89.95% to $3.97. It experienced higher than average volume on day. The stock increased in value by almost 60.08% over the past week and grew 7519.96% in the past month. It is currently trading 1335.9% above its 50 day moving average and 933.04% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a 42.29% increase in value from its one year high of $4.98. The RSI indicator value of 88.02, lead us to believe that it may reverse gains in the near term.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

 

3 Trending Stocks: EnteroMedics Inc. (ETRM), Memorial Production Partners LP (MEMP), NVIDIA Corporation (NVDA)

EnteroMedics Inc. (ETRM) managed to rebound with the stock declining -7.52% or $0 to close the day at $0.05 on active trading volume of 16.79M shares, compared to its three month average trading volume of 10.77M. The St. Paul Minnesota 55113 based company has been underperforming the medical appliances & equipment group over the past 52 weeks, with the stock losing -97.24%, compared to the industry which has advanced 3.77% over the same period. With RSI of 37.46, the stock should still continue to rise and get closer to its one year target estimate of $2, making it a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Memorial Production Partners LP (MEMP) fell -56.1% during last trading as the stock lost $-0.23 to finish the day at $0.18 with about 16.36M shares changing hands, compared to its three month average trading volume of 1.48M. The $34.3M market cap company, currently situated -43.75% below its 52 week low of $0.15 and -94.2% away from its one year high of $3.21. The RSI of 26.56 indicates the stock is oversold at the current levels, buy for now.

Memorial Production Partners LP, through its subsidiary, Memorial Production Operating LLC, engages in the acquisition, development, exploitation, and production of oil and natural gas properties. Its properties consist of operated and non-operated working interests in producing and undeveloped leasehold acreage, as well as working interests in identified producing wells located in Texas, Louisiana, Colorado, Wyoming, and offshore Southern California. As of December 31, 2015, its total estimated proved reserves were approximately 1,268 billion cubic feet of natural gas equivalent. Memorial Production Partners GP LLC serves as the general partner of Memorial Production Partners LP. The company was founded in 2011 and is headquartered in Houston, Texas.

NVIDIA Corporation (NVDA) saw its value increase by 2.49% as the stock gained $2.67 to finish the day at a closing price of $109.78. The stock was higher in trading and has fluctuated between $24.75-$109.83 per share for the past year. The shares are up by 70.88% in the past three months and up by 143.47% over the past six months. It is currently trading 14.86% above its 20 day moving average and 31.63% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $92.65 a share over the next twelve months. The current relative strength index (RSI) reading is 77.91. The technical indicator do not lead us to believe the stock will see more gains any time soon.

NVIDIA Corporation operates as a visual computing company worldwide. It operates in two segments, GPU and Tegra Processor. The GPU segment offers processors, which include GeForce for PC gaming; Quadro for design professionals working in computer-aided design, video editing, special effects, and other creative applications; Tesla for deep learning, accelerated computing, and general purpose computing; and GRID for cloud-based streaming on gaming devices. The Tegra Processor segment provides processors that integrate a computer onto a single chip under the Tegra brand name; DRIVE automotive computers, which offer supercomputing capabilities; and tablet and portable devices for mobile gaming under the SHIELD name. The company’s products are used in gaming, professional visualization, datacenter, and automotive markets. It sells its products primarily to original equipment manufacturers, original design manufacturers, system builders, motherboard manufacturers, add-in board manufacturers, and retailers/distributors. NVIDIA Corporation was founded in 1993 and is headquartered in Santa Clara, California.

 

Stocks Under Review: Twenty-First Century Fox, Inc. (FOXA), EnteroMedics Inc. (ETRM), Uranium Resources, Inc. (URRE)

Twenty-First Century Fox, Inc. (FOXA) failed to extend gains with the stock declining -0.07% or $-0.02 to close the day at $28.43 on active trading volume of 7.45M shares, compared to its three month average trading volume of 11.64M. The New York New York 10036 based company has been outperforming the entertainment – diversified group over the past 52 weeks, with the stock gaining 5.12%, compared to the industry which has advanced 14.97% over the same period. With RSI of 58.24, the stock should still continue to rise and get closer to its one year target estimate of $31.4, making it a hold for now.

Twenty-First Century Fox, Inc., together with its subsidiaries, operates as a diversified media and entertainment company in the United States, the United Kingdom, Continental Europe, Asia, Latin America, and internationally. It operates through Cable Network Programming; Television; Filmed Entertainment; and Other, Corporate and Eliminations segments. The company produces and licenses news, sports, movie, and general and factual entertainment programming for distribution primarily through cable television systems, direct broadcast satellite operators, telecommunications companies, and online video distributors. It also broadcasts network programming; and operates 28 broadcast television stations, including 11 duopolies in the United States. In addition, the company produces and acquires live-action and animated motion pictures for distribution and licensing in various formats and entertainment media, as well as produces and licenses television programming worldwide. Further, it offers video advertising services, including consumer engagement and on-demand marketing campaigns; and operates two San Francisco-Bay area television stations. The company was formerly known as News Corporation. Twenty-First Century Fox, Inc. was founded in 1922 and is headquartered in New York, New York.

EnteroMedics Inc. (ETRM) retreated with the stock falling -0.81% or $0 to close at $0.05 on active trading volume of 7.28M compared its three months average trading volume of 10.75M. The St. Paul Minnesota 55113 based company operating under the Medical Appliances & Equipment industry has been trending down for the last 52 weeks, with the shares price now -97.27% down for the period and down by -97.48% so far this year. With price target of $2 and a 18.55% rebound from 52-week low, EnteroMedics Inc. has plenty of upside potential, making it a hold with a view buy.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Uranium Resources, Inc. (URRE) managed to rebound with the stock climbing 31.19% or $0.34 to close the day at $1.43 on lower than average trading volume of 7.21M shares, compared to its three month average trading volume of 709.47K. The Centennial Colorado 80112 based company has been outperforming the industrial metals & minerals companies by -0.1459% for last three months and its recent losses have trimmed gains to -77.08% YTD, versus the industrial metals & minerals industry which is up 54.48% for the same period. The RSI of 55.72 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Uranium Resources, Inc. explores for, develops, and produces uranium. The company has in-situ recovery (ISR) projects and two licensed processing facilities. It owns and operates the Temrezli ISR project in Central Turkey; and controls exploration properties under nine exploration and operating licenses covering approximately 32,000 acres with various exploration targets, including the Sefaatli project. The company also holds interest in approximately 190,000 acres of mineral holdings in the prolific Grants Mineral Belt of the State of New Mexico; and 14,000 acres in the South Texas uranium province. In addition, it holds an agreement to acquire certain placer mining claims in the Sal Rica lithium brine project that covers an area of approximately 9,800 acres located in the Pilot Valley region of northwestern Utah. Uranium Resources, Inc. was founded in 1977 and is based in Centennial, Colorado.

 

Stocks in Review: EnteroMedics Inc. (ETRM), Citigroup Inc. (C), Sirius XM Holdings Inc. (SIRI)

EnteroMedics Inc. (ETRM) traded within a range of $0.0475 to $0.056 after opening the day at $0.05. The company has seen its stock decrease in value by -97.46% so far this year. The stock was down close to -0.8% on active volume in last trading session and closed at $0.05 per share. After the recent fall, the stock is currently holding -98.16% below its 52 week high of $2.697 and 19.52% above its 12-month low of $0.0415. The shares are down by over -63.93% in the last three months, and the RSI indicator value of 39.96 is neither bullish nor bearish, tempting investors to stay on the sidelines.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Citigroup Inc. (C) failed to extend gains with the stock declining -0.08% or $-0.05 to close the day at $60.75 on light trading volume of 15.08M shares, compared to its three month average trading volume of 21.72M. The New York New York 10013 based company has been outperforming the money center banks group over the past 52 weeks, with the stock gaining 17.89%, compared to the industry which has dropped -6.16% over the same period. With RSI of 71.12, the stock should still continue to rise and get closer to its one year target estimate of $61.09, making it a hold for now.

Citigroup Inc., a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions worldwide. It operates through two segments, Citicorp and Citi Holdings. The Citicorp segment offers traditional banking services to retail customers through retail banking, commercial banking, Citi-branded cards, and Citi retail services. This segment also provides various banking, credit card lending, and investment services through a network of local branches, offices, and electronic delivery systems. In addition, it offers wholesale banking products and services to corporate, institutional, public sector, and high-net-worth clients. Further, this segment provides fixed income and equity sales and trading, foreign exchange, prime brokerage, derivative services, equity and fixed income research, corporate lending, investment banking and advisory services, private banking, cash management, trade finance, and securities services. As of December 31, 2015, it operated 2,994 branches in 24 countries. The Citi Holdings segment provides consumer loans; portfolio of securities, loans, and other assets; and retail alternative investment and other services. Citigroup Inc. was founded in 1812 and is based in New York, New York.

Sirius XM Holdings Inc. (SIRI) dropped $0 to close the day at a new closing price of $4.53, a 0% decrease in value from its previous closing price that moved the stock 38.02% above its 52 week low of $3.29. A total of 15.02M shares exchanged hands during the day compared with its three month average trading volume of 41.6M. The stock, which fluctuated between $4.52 and $4.57 during the day, currently situated -2.58% below its 52 week high. The stock is down by -0.88% in the past one month and up by 7.86% over the past three months. With a one year target estimate of $4.89 and RSI of 55.44, the stock still has upside potential, making it a hold for now.

Sirius XM Holdings Inc. provides satellite radio services in the United States. The company broadcasts music plus sports, entertainment, comedy, talk, news, traffic, and weather programs, including various music genres ranging from rock, pop and hip-hop to country, dance, jazz, Latin, and classical; live play-by-play sports from principal leagues and colleges; multitude of talk and entertainment channels for various audiences; national, international, and financial news; and local traffic and weather reports for 21 metropolitan markets. It also streams music and non-music channels over the Internet; and offer applications to allow consumers to access its Internet radio service on smartphones and tablet computers. In addition, the company distributes satellite radios through the sale and lease of new vehicles; and acquires subscribers through the sale and lease of previously owned vehicles with factory-installed satellite radios. Its satellite radio systems include satellites, terrestrial repeaters, and other satellite facilities; studios; and radios. Further, the company provides satellite television services, which offer music channels on the DISH NETWORK satellite television service as a programming package; Travel Link, a suite of data services that include graphical weather, fuel prices, sports schedule and scores, and movie listings; real-time traffic services; and real-time weather services. Additionally, it offers location-based services through two-way wireless connectivity, including safety, security, convenience, maintenance and data services, remote vehicles diagnostics, stolen or parked vehicle locator services, and monitoring of vehicle emission systems. The company also sells satellite and Internet radios directly to consumers through its Website, as well as through national and regional retailers. The company was founded in 1990 and is headquartered in New York, New York. Sirius XM Holdings Inc. operates as a subsidiary of Liberty Media Corporation.